Plasminogen activator

Plasminogen activator is a type of enzyme that is responsible for the conversion of plasminogen to plasmin – a crucial step in the process of fibrinolysis. There are two main types of plasminogen activators: tissue plasminogen activator (tPA) and urokinase (uPA).

Function

Plasminogen activators play a vital role in the blood clotting process. They convert plasminogen, a protein found in the blood, into plasmin. Plasmin is an enzyme that breaks down fibrin, a protein that forms a mesh-like structure to create a blood clot. This process, known as fibrinolysis, helps to prevent the formation of large, potentially dangerous blood clots.

Types

There are two main types of plasminogen activators:

• Tissue plasminogen activator (tPA): This type of plasminogen activator is produced by the endothelial cells that line the blood vessels. It is released into the blood in response to certain signals, such as a drop in blood pressure or an increase in blood flow.

• Urokinase (uPA): This type of plasminogen activator is produced by the kidneys and is found in the urine. It is also produced by certain types of cells in the body, including macrophages and fibroblasts.

Clinical significance

Plasminogen activators have important clinical applications, particularly in the treatment of thrombosis. Drugs that mimic the action of plasminogen activators, known as thrombolytics, can be used to dissolve blood clots and restore normal blood flow. Examples of these drugs include alteplase, reteplase, and tenecteplase, which are all forms of tPA.

See also

• Fibrinolysis
• Thrombolysis
• Blood clotting

References

Plasminogen activator Resources
Latest articles Most recent articles Ongoing trials	Wikipedia